Astrocytosis in parkinsonism: Considering tripartite striatal synapses in physiopathology?

Frontiers in Aging Neuroscience

Volumn 6, Issue SEP, 2014, Pages

  Charron, Giselle ^a,b   Doudnikoff, Evelyne ^a,b   Canron, Marie Helene ^a,b   Li, Qin ^d   Ve´ga, Ce´line ^b,e   Marais, Sebastien ^f   Baufreton, Je´roˆme ^a,b   Vital, Anne ^a,b   Oliet, Ste´phane H R ^c   Bezard, Erwan ^a,b,d  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

^c INSTITUT FRANÇOIS MAGENDIE   (France)

^d INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^e SORBONNE UNIVERSITÉ   (France)

^f University of Bordeaux   (France)

Author keywords

Astrocyte; Dopamine; Human; Immunohistochemistry; Medium spiny neuron; Monkey; Mouse; Rat

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; BASAL GANGLION; CELL STRUCTURE; CONTROLLED STUDY; CORPUS STRIATUM; HUMAN; HUMAN TISSUE; HYPOTHESIS; MALE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; RAT; REGULATORY MECHANISM; SYNAPSE; TRIPARTITE STRIATAL SYNAPSE;

EID: 84907180250     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00258     Document Type: Article

References (68)

1. Ball, K.K., Gandhi, G.K., Thrash, J., Cruz, N.F., and Dienel, G.A. (2007). Astrocytic connexin distributions and rapid, extensive dye transfer via gap junctions in the inferior colliculus: implications for [(14)C]glucose metabolite trafficking. J Neurosci Res 85, 3267-3283. doi: 10.1002/jnr.21376.
2. Berthet, A., Bezard, E., Porras, G., Fasano, S., Barroso-Chinea, P., Dehay, B., Martinez, A., Thiolat, M.L, Nosten-Bertrand, M., Giros, B., Baufreton, J., Li, Q., Bloch, B., and Martin-Negrier, M.L. (2012). LDOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor. J Neurosci 32, 681-691. doi: 10.1523/jneurosci.1541-11.2012.
3. Berthet, A., Porras, G., Doudnikoff, E., Stark, H., Cador, M., Bezard, E., and Bloch, B. (2009). Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia. J Neurosci 29, 4829-4835.
4. Boyes, B.E., Kim, S.U., Lee, V., and Sung, S.C. (1986). Immunohistochemical co-localization of S-100b and the glial fibrillary acidic protein in rat brain. Neuroscience 17, 857-865. doi: 0306-4522(86)90050-3 [pii].
5. Braak, H., Sastre, M., and Del Tredici, K. (2007). Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Acta Neuropathol 114, 231-241. doi: 10.1007/s00401-007-0244-3.
6. Bushong, E.A., Martone, M.E., Jones, Y.Z., and Ellisman, M.H. (2002). Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 22, 183-192.
7. Calabresi, P., Centonze, D., Gubellini, P., Marfia, G.A., Pisani, A., Sancesario, G., and Bernardi, G. (2000). Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog. Neurobiol. 61, 231-265.
8. Charron, G., Doudnikoff, E., Laux, A., Berthet, A., Porras, G., Canron, M.H., Barroso-Chinea, P., Li, Q., Qin, C, Nosten-Bertrand, M., Giros, B., Delalande, F., Van Dorsselaer, A., Vital, A., Goumon, Y., and Bezard, E. (2011). Endogenous morphine-like compound immunoreactivity increases in parkinsonism. Brain 134, 2321-2338. doi: 10.1093/brain/awr166.
9. Chaudhry, F.A., Lehre, K.P., Van Lookeren Campagne, M., Ottersen, O.P., Danbolt, N.C., and Storm-Mathisen, J. (1995). Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15, 711-720.
10. Danbolt, N.C. (2001). Glutamate uptake. Prog Neurobiol 65, 1-105.
11. Day, M., Wang, Z., Ding, J., An, X., Ingham, C.A., Shering, A.F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A.R., Mugnaini, E., Deutch, A.Y., Sesack, S.R., Arbuthnott, G.W., and Surmeier, D.J. (2006). Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9, 251-259.
12. Dermietzel, R., Gao, Y., Scemes, E., Vieira, D., Urban, M., Kremer, M., Bennett, M.V., and Spray, D.C. (2000). Connexin43 null mice reveal that astrocytes express multiple connexins. Brain Res Brain Res Rev 32, 45-56.
13. Dermietzel, R., Hertberg, E.L., Kessler, J.A., and Spray, D.C. (1991). Gap junctions between cultured astrocytes: immunocytochemical, molecular, and electrophysiological analysis. J Neurosci 11, 1421-1432.
14. Dervan, A.G., Meshul, C.K., Beales, M., Mcbean, G.J., Moore, C, Totterdell, S., Snyder, A.K., and Meredith, G.E. (2004). Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease. Exp Neurol 190, 145-156. doi: 10.1016/j.expneurol.2004.07.004.
15. Donnelly, C.J., Zhang, P.W., Pham, J.T., Heusler, A.R., Mistry, N.A., Vidensky, S., Daley, E.L., Poth, E.M., Hoover, B., Fines, D.M., Maragakis, N., Tienari, P.J., Petrucelli, L., Traynor, B.J., Wang, J., Rigo, F., Bennett, C.F., Blackshaw, S., Sattler, R., and Rothstein, J.D. (2013). RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80, 415-428. doi: 10.1016/j.neuron.2013.10.015.
16. Dumartin, B., Caille´, I., Gonon, F., and Bloch, B. (1998). Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists. J. Neurosci. 18, 1650-1651.
17. Dumartin, B., Jaber, M., Gonon, F., Caron, M., Giros, B., and Bloch, B. (2000). Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine trasnporter deficient mice. Proc. Natl. Acad. Sci. USA 97, 1879-1884.
18. Ehringer, H., and Hornykiewicz, O. (1960). Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wochenschr. 38, 1236-1239.
19. Fasano, S., Bezard, E., D'antoni, A., Francardo, V., Indrigo, M., Qin, L., Dovero, S., Cerovic, M., Cenci, M.A., and Brambilla, R. (2010). Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia. Proc Natl Acad Sci USA 107, 21824-21829. doi: 10.1073/pnas.1012071107.
20. Fernagut, P.O., Li, Q., Dovero, S., Chan, P., Wu, T., Ravenscroft, P., Hill, M., Chen, Z., and Bezard, E. (2010). Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys. Plos One 5, e14053.
21. Gerfen, C.R., and Surmeier, D.J. (2011). Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34, 441-466. doi: 10.1146/annurev-neuro-061010-113641.
22. Giaume, C, Koulakoff, A., Roux, L, Holcman, D., and Rouach, N. (2010). Astroglial networks: a step further in neuroglial and gliovascular interactions. Nat Rev Neurosci 11, 87-99. doi: 10.1038/nrn2757.
23. Giaume, C, Leybaert, L, Naus, C.C., and Saez, J.C. (2013). Connexin and pannexin hemichannels in brain glial cells: properties, pharmacology, and roles. Front Pharmacol 4, 88. doi: 10.3389/fphar.2013.00088.
24. Giaume, C, and Mccarthy, K.D. (1996). Control of gap-junctional communication in astrocytic networks. Trends Neurosci 19, 319-325.
25. Giaume, C, and Theis, M. (2010). Pharmacological and genetic approaches to study connexin-mediated channels in glial cells of the central nervous system. Brain Res Rev 63, 160-176. doi: 10.1016/j.brainresrev.2009.11.005.
26. Gomide, V., and Chadi, G. (2005). Glial bFGF and S100 immunoreactivities increase in ascending dopamine pathways following striatal 6-OHDA-induced partial lesion of the nigrostriatal system: a sterological analysis. IntJ Neurosci 115, 537-555. doi: 10.1080/00207450590521064.
27. Goubard, V., Fino, E., and Venance, L. (2011). Contribution of astrocytic glutamate and GABA uptake to corticostriatal information processing. J. Physiol. 589, 2301-2319.
28. Guigoni, C, Doudnikoff, E., Li, Q., Bloch, B., and Bezard, E. (2007). Altered D1 dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Neurobiol. Dis. 26, 452-463.
29. Halliday, G.M., and Stevens, C.H. (2011). Glia: initiators and progressors of pathology in Parkinson's disease. Mov Disord 26, 6-17. doi: 10.1002/mds.23455.
30. Henning, J., Strauss, U., Wree, A., Gimsa, J., Rolfs, A., Benecke, R., and Gimsa, U. (2008). Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease. Neurosci Res 62, 246-253. doi: 10.1016/j.neures.2008.09.001.
31. Hirsch, E.C., Breidert, T., Rousselet, E., Hunot, S., Hartmann, A., and Michel, P.P. (2003). The role of glial reaction and inflammation in Parkinson's disease. Ann N Y Acad Sci 991, 214-228.
32. Hofer, A., and Dermietzel, R. (1998). Visualization and functional blocking of gap junction hemichannels (connexons) with antibodies against external loop domains in astrocytes. Glia 24, 141-154.
33. Houades, V., Rouach, N., Ezan, P., Kirchhoff, F., Koulakoff, A., and Giaume, C. (2006). Shapes of astrocyte networks in the juvenile brain. Neuron Glia Biol 2, 3-14. doi: 10.1017/S1740925X06000081.
34. Ingham, C.A., Hood, S.H., and Arbuthnott, G.W. (1989). Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res 503, 334-338.
35. Kullmann, D.M., and Asztely, F. (1998). Extrasynaptic glutamate spillover in the hippocampus: evidence and implications. Trends Neurosci 21, 8-14.
36. Lee, H.J., Suk, J.E., Patrick, C, Bae, E.J., Cho, J.H., Rho, S., Hwang, D., Masliah, E., and Lee, S.J. (2010). Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285, 9262-9272. doi: M109.081125 [pii]
37. Lehre, K.P., Levy, L.M., Ottersen, O.P., Storm-Mathisen, J., and Danbolt, N.C. (1995). Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 15, 1835-1853.
38. Mcgeer, P.L, and Mcgeer, E.G. (2008). Glial reactions in Parkinson's disease. Mov Disord 23, 474-483. doi: 10.1002/mds.21751.
39. Meme, W., Calvo, C.F., Froger, N., Ezan, P., Amigou, E., Koulakoff, A., and Giaume, C. (2006). Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid. FASEBJ 20, 494-496. doi: 10.1096/fj.05-4297fje.
40. Muramatsu, Y., Kurosaki, R., Watanabe, H., Michimata, M., Matsubara, M., Imai, Y., and Araki, T. (2003). Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Glia 42, 307-313. doi: 10.1002/glia. 10225.
41. Nagy, J.I., Patel, D., Ochalski, P.A., and Stelmack, G.L. (1999). Connexin30 in rodent, cat and human brain: selective expression in gray matter astrocytes, co-localization with connexin43 at gap junctions and late developmental appearance. Neuroscience 88, 447-468.
42. Nedergaard, M., and Verkhratsky, A. (2012). Artifact versus reality--how astrocytes contribute to synaptic events. Glia 60, 1013-1023. doi: 10.1002/glia.22288.
43. Nicola, S.M., Surmeier, J., and Malenka, R.C. (2000). Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 23, 185-215. doi: 10.1146/annurev.neuro.23.1.185.
44. Oberheim, N.A., Takano, T., Han, X., He, W., Lin, J.H., Wang, F., Xu, Q., Wyatt, J.D., Pilcher, W., Ojemann, J.G., Ransom, B.R., Goldman, S.A., and Nedergaard, M. (2009). Uniquely hominid features of adult human astrocytes. J Neurosci 29, 3276-3287. doi: 10.1523/jneurosci.4707-08.2009.
45. Parpura, V., Heneka, M.T., Montana, V., Oliet, S.H., Schousboe, A., Haydon, P.G., Stout, R.F., Jr., Spray, D.C., Reichenbach, A., Pannicke, T., Pekny, M., Pekna, M., Zorec, R., and Verkhratsky, A. (2012). Glial cells in (patho)physiology. J Neurochem 121, 4-27. doi: 10.1111/j.1471-4159.2012.07664.x.
46. Pellerin, L., and Magistretti, P.J. (1994). Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91, 10625-10629.
47. Perea, G., Navarrete, M., and Araque, A. (2009). Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 32, 421-431. doi: 10.1016/j.tins.2009.05.001.
48. Picconi, B., Piccoli, G., and Calabresi, P. (2012). Synaptic dysfunction in Parkinson's disease. Adv Exp Med Biol 970, 553-572. doi: 10.1007/978-3-7091-0932-8_24.
49. Porras, G., Berthet, A., Dehay, B., Li, Q., Ladepeche, L., Normand, E., Dovero, S., Martinez, A., Doudnikoff, E., Martin-Negrier, M.L., Chuan, Q., Bloch, B., Choquet, D., Boue-Grabot, E., Groc, L., and Bezard, E. (2012). PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking. J Clin Invest 122, 3977-3989. doi: 59426 [pii] 10.1172/JCI59426.
50. Raju, D.V., Ahern, T.H., Shah, D.J., Wright, T.M., Standaert, D.G., Hall, R.A., and Smith, Y. (2008). Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism. Eur J Neurosci 27, 1647-1658. doi: 10.1111/j.1460-9568.2008.06136.x.
51. Raponi, E., Agenes, F., Delphin, C, Assard, N., Baudier, J., Legraverend, C, and Deloulme, J.C. (2007). S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage. Glia 55, 165-177. doi: 10.1002/glia.20445.
52. Rothstein, J.D., Dykes-Hoberg, M., Pardo, C.A., Bristol, L.A., Jin, L., Kuncl, R.W., Kanai, Y., Hediger, M.A., Wang, Y., Schielke, J.P., and Welty, D.F. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.
53. Rouach, N., Koulakoff, A., Abudara, V., Willecke, K., and Giaume, C. (2008). Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322, 1551-1555. doi: 10.1126/science. 1164022.
54. Santello, M., Cali, C, and Bezzi, P. (2012). Gliotransmission and the tripartite synapse. Adv Exp Med Biol 970, 307-331. doi: 10.1007/978-3-7091-0932-8_14.
55. Santini, E., Sgambato-Faure, V., Li, Q., Savasta, M., Dovero, S., Fisone, G., and Bezard, E. (2010). Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia. Plos ONE5, e12322. doi:12310.11371/journal.pone.0012322.
56. Sathe, K., Maetzler, W., Lang, J.D., Mounsey, R.B., Fleckenstein, C, Martin, H.L., Schulte, C, Mustafa, S., Synofzik, M., Vukovic, Z., Itohara, S., Berg, D., and Teismann, P. (2012). S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway. Brain 135, 3336-3347. doi: aws250 [pii] 10.1093/brain/aws250.
57. Scholz, B., Svensson, M., Alm, H., Skold, K., Falth, M., Kultima, K., Guigoni, C, Doudnikoff, E., Li, Q., Crossman, A.R., Bezard, E., and Andren, P.E. (2008). Striatal Proteomic Analysis Suggests that First L-Dopa Dose Equates to Chronic Exposure. PLoS ONE 3, e1589.
58. Schuster, S., Doudnikoff, E., Rylander, D., Berthet, A., Aubert, I., Ittrich, C, Bloch, B., Cenci, M.A., Surmeier, D.J., Hengerer, B., and Bezard, E. (2009). Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol Psychiatry 65, 518-526.
59. Shu, S.Y., Ju, G., and Fan, L.Z. (1988). The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 85, 169-171.
60. Sorci, G., Bianchi, R., Riuzzi, F., Tubaro, C, Arcuri, C, Giambanco, I., and Donato, R. (2010). S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond. Cardiovasc Psychiatry Neurol 2010. doi: 10.1155/2010/656481.
61. Suarez, L.M., Solis, O., Carames, J.M., Taravini, I.R., Solis, J.M., Murer, M.G., and Moratalla, R. (2014). LDOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. Biol Psychiatry 75, 711-722. doi: 10.1016/j.biopsych.2013.05.006.
62. Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., Okuyama, S., Kawashima, N., Hori, S., Takimoto, M., and Wada, K. (1997). Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276, 1699-1702.
63. Tsacopoulos, M., and Magistretti, P.J. (1996). Metabolic coupling between glia and neurons. J Neurosci 16, 877-885.
64. Van Eldik, L.J., and Zimmer, D.B. (1987). Secretion of S-100 from rat C6 glioma cells. Brain Res 436, 367-370. doi: 0006-8993(87)91681-7 [pii].
65. Villalba, R.M., and Smith, Y. (2011). Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease. Front Syst Neurosci 5, 68. doi: 10.3389/fnsys.2011.00068.
66. Vital, A., Fernagut, P.O., Canron, M.H., Joux, J., Bezard, E., Martin-Negrier, M.L., Vital, C, and Tison, F. (2009). The nigrostriatal pathway in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 68, 809-815. doi: 10.1097/NEN.0b013e3181abdae8.
67. Wilhelmsson, U., Bushong, E.A., Price, D.L., Smarr, B.L., Phung, V., Terada, M., Ellisman, M.H., and Pekny, M. (2006). Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci USA 103, 17513-17518. doi: 10.1073/pnas.0602841103.
68. Zhang, Y., Meredith, G.E., Mendoza-Elias, N., Rademacher, D.J., Tseng, K.Y., and Steece-Collier, K. (2013). Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses. J Neurosci 33, 11655-11667. doi: 10.1523/JNEUROSCI.0288-13.2013.